Exemestane Prescribing at AMMONITE HEALTH PARTNERSHIP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
140
Total Quantity
4,410
NHS Cost
£826
vs National Avg
+330.9%
AMMONITE HEALTH PARTNERSHIP prescribed 140 items of Exemestane over the last 12 months at a cost of £826 to the NHS. This is 330.9% above the national average prescribing rate. Exemestane is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
12
Jul 2026
15
Jul 2026
11
Jul 2026
11
Jul 2026
10
Jul 2026
13
Jul 2026
8
Jul 2026
14
Jul 2026
11
Jul 2026
14
Jul 2026
9
Jul 2026
12
Prescribing Details
| Total Items | 140 |
|---|---|
| Total Quantity | 4,410 |
| Total NHS Cost | £826 |
| Presentations | 1 different forms |
| vs National Average | +330.9% |
Exemestane Prescribing Comparison
| This practice | 140 items |
|---|---|
| National average per practice | 33 items |
| Difference | +330.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.